Related Experiment Video
Updated: May 19, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
[Clinical features of chronic granulomatous disease]
Wen-jing Ying1, Xiao-chuan Wang, Jin-qiao Sun
1Department of Clinical Immunology, Institute of Pediatrics, Children's Hospital of Fudan University, Shanghai 201102, China.
Insights
Chronic granulomatous disease (CGD) in Chinese children often presents with early onset and recurrent infections. Early diagnosis and treatment with recombinant human interferon-gamma (rhIFN-γ) can improve outcomes for this rare immunodeficiency.
Area of Science:
- Immunology
- Genetics
- Pediatrics
Context:
- Chronic granulomatous disease (CGD) is a rare primary immunodeficiency.
- Phagocytic oxidative bursts are impaired in CGD, leading to severe infections and granuloma formation.
- Limited data exists on CGD clinical characteristics in China.
Purpose:
- To evaluate the clinical features of 48 Chinese CGD cases.
- Confirm diagnoses using dihydrorhodamine (DHR) assay and gene mutation analysis.
Summary:
- The study analyzed 48 Chinese CGD patients diagnosed between 2004 and 2011.
- All patients were diagnosed by DHR analysis, with onset typically before six months.
- Common symptoms included recurrent respiratory infections, chronic diarrhea, skin lesions, and lymphadenectasis, often linked to BCG vaccination.
- Mycobacteria, fungi, and pyogenic bacteria were the primary pathogens.
- Mutations in CYBB/CYBA/NCF1/NCF2 genes were identified in 37 patients.
- Treatment with recombinant human interferon-gamma (rhIFN-γ) and sulfamethoxazole reduced disease frequency and severity.
Impact:
- CGD in this cohort presented with younger age at onset and diagnosis compared to previous reports.
- Clinical manifestations involved multiple systems, including respiratory, alimentary, skin, and lymph nodes.
- rhIFN-γ showed potential in improving CGD prognosis.
Objective:
Chronic granulomatous disease (CGD) is a rare primary immunodeficiency of phagocytic oxidative bursts leading to recurrent severe bacterial and fungal infections as well as granuloma formation. There were few reports on the clinical characteristics of this disease in China. The purpose of this study was to evaluate the clinical features of 48 Chinese cases with CGD which were confirmed by clinical features, dihydrorhodamine (DHR) assay and gene mutation analysis.
Method:
The study cohort was the population of CGD patients diagnosed in Children's Hospital of Fudan University from January, 2004, to June, 2011. Cases included in our analysis were restricted to those who had complete data of the clinical symptoms and laboratory tests. The patients were followed up by outpatient visiting and telephone call regularly for 0.5 to 6 years. The history and data of physical examination and treatment of 48 cases were collected and reviewed.
Result:
All the patients were diagnosed by DHR analysis. The age of onset of all the 48 patients were less than 6 months, including 43 male and 5 female. The mean age at diagnosis was 2.42 years; 12 patients were infants under six months, 10 were between 6 and 12 months, 9 were between 1 and 2 years, 5 patients were between 2 and 3 years, 4 were between 4 and 5 years, and 8 were between 6 and 10 years. Recurrent respiratory infection (44/48) and chronic diarrhea (31/48) were the common symptoms in all the patients, and then skin lesion (22/48), including marked reaction at BCG infected site, pustular eruption and infected skin ulcer and urinary tract infection (3/48) were also general symptoms in our study. In addition, lymphadenectasis occurred in 31 cases and 23 of them were considered to be associated with BCG vaccination. The pathogens caused the infection were mycobacteria (52.08%), fungi (43.75%) and pyogenic bacteria. Thirty-seven patients had mutations in CYBB/CYBA/NCF1/NCF2 genes. Recombinant human interferon-gamma (rhIFN-γ) plus sulfamethoxazole were used for the prevention and treatment of infection, the frequency and severity of the disease could be reduced.
Conclusion:
The age at onset and diagnosis of the present group of CGD was younger. Clinical symptoms were associated with recurrent mycobacterial, fungal and pyogenic bacterial infection, which involved respiratory tract, alimentary tract, skin and lymph node. rhIFN-γ partially improved the prognosis of CGD.
Related Concept Videos
Chronic Inflammation: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...